Welcome to our dedicated page for Delek Us Hldgs SEC filings (Ticker: DK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Delek US Holdings, Inc. (NYSE: DK) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. Delek US uses Form 8-K filings to furnish quarterly earnings releases, dividend announcements, investor presentations, and earnings call slides, giving investors a structured view of its financial condition and strategic messaging.
Through Item 2.02 of Form 8-K, Delek US reports results of operations and financial condition, including net income or loss, Adjusted net income, Adjusted EBITDA, and segment-level performance for refining and logistics. These filings often reference non-GAAP measures such as refining margin, adjusted refining margin, refining production margin, and net debt, along with reconciliations to GAAP metrics described in accompanying tables.
Item 7.01 Regulation FD disclosures in Delek US 8-Ks typically include earnings call slides and investor presentations. The company notes that these materials are furnished, not filed, and may be used in presentations to existing and prospective investors. Item 8.01 is used for other events, such as Board-approved quarterly dividends per share, with details on record and payment dates.
On this page, Stock Titan’s AI summarizes the key points from each filing so users can quickly understand what changed in Delek US’s business, capital allocation, and midstream relationship with Delek Logistics Partners, LP. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while AI-generated highlights help clarify complex sections, such as non-GAAP definitions and regulatory language, without replacing the need to review the full original documents.
Form 144 notice: A holder of the issuer’s common stock filed to sell 110,000 shares through J.P. Morgan Securities LLC. The filing lists an aggregate market value of $4,730,000 for the proposed sale, with 60,152,407 shares outstanding and an approximate sale date of 11/07/2025 on the NYSE.
The filing also details how the seller originally acquired shares, including multiple transfers from Ezra Uzi Yemin tied to compensation grants on dates such as 08/08/2012, 03/10/2016, 03/10/2017, 12/10/2017, and 03/10/2019. Recent activity is disclosed: sales in the past three months by Yemin Investments LP and by Ezra Uzi Yemin. Examples include 76,929 shares sold on 10/24/2025 for $2,935,711 and 20,980 shares sold on 10/24/2025 for $800,624.
This is a notice of a potential secondary sale under Rule 144 by existing holders; proceeds from such sales go to the selling holders rather than the company.
Delek US Holdings (DK) reported a profitable Q3 2025. Net revenues were $2,887.0 million versus $3,042.4 million a year ago, while operating income reached $295.7 million compared with a prior-year operating loss of $121.9 million. Net income attributable to Delek was $178.0 million, and diluted EPS was $2.93, reflecting stronger refining margins and lower costs.
For the first nine months, net revenues were $8,293.5 million and the company recorded a net loss attributable to Delek of $101.1 million. Cash and cash equivalents were $630.9 million as of September 30, 2025. Long‑term debt, net of current portion, was $3,167.8 million.
The Logistics segment included the Gravity Acquisition completed on January 2, 2025 for total consideration of $300.8 million, contributing revenue and net income of $67.5 million and $24.0 million, respectively, for the period through September 30, 2025. Prior-year results included a gain from discontinued retail operations following the September 30, 2024 divestiture. Shares outstanding were 60,051,553 as of October 31, 2025.
Delek US Holdings (DK) announced its financial results for the quarter ended September 30, 2025. The company furnished a press release as Exhibit 99.1 and plans to use Exhibit 99.2 (Earnings Call Slides) in connection with its third‑quarter earnings call. These materials are furnished, not filed, under Items 2.02 and 7.01 and will also be available on the company’s website.
Delek US Holdings (DK): Form 4 insider transaction. Director Ezra Uzi Yemin reported open‑market sales of common stock on 10/29/2025. He sold 1,581 shares at a weighted average price of $38.08 and, through Yemin Investments, LP, sold 5,807 shares at the same weighted average price.
Following these transactions, beneficial ownership stood at 166,580.047 shares held directly and 723,145 shares held indirectly by Yemin Investments, LP. The trades were made pursuant to a Rule 10b5‑1 plan. The reported price reflects a weighted average of multiple sales ranging from $38.00 to $38.30 per share, with full breakdowns available upon written request.
Delek US Holdings announced a quarterly cash dividend of $0.255 per share. The dividend will be paid on November 17, 2025 to shareholders of record as of November 10, 2025.
This action reflects the company’s ongoing return of capital policy. The company also issued a press release with further details, furnished as Exhibit 99.1.
Delek US Holdings (DK): Director Ezra Uzi Yemin reported open‑market sales made pursuant to a Rule 10b5‑1 plan. On 10/23/2025, he sold 7,249 shares of common stock at a weighted average price of $38.04 (direct) and 26,578 shares at $38.04 (indirect via Yemin Investments, LP). On 10/24/2025, he sold 20,982 shares at $38.16 (direct) and 76,927 shares at $38.16 (indirect). On 10/27/2025, he sold 188 shares at $38.01 (direct) and 688 shares at $38.01 (indirect).
Following these transactions, beneficial ownership stood at 168,161.047 shares direct and 728,952 shares indirect.
DK received a Form 144 notice indicating a planned sale of 110,000 common shares through J.P. Morgan Securities LLC, with an aggregate market value of $4,180,000. The filing lists an approximate sale date of 10/23/2025 on the NYSE.
The table shows these shares were originally acquired via transfers from Ezra Uzi Yemin across several dates in 2018–2019. As context, 60,152,407 shares were outstanding at the time referenced in the notice; this is a baseline figure, not the amount being sold.
DK: A Form 144 notice indicates an intended sale of 30,000 common shares with an aggregate market value of $1,140,000. The approximate sale date is 10/23/2025, and the shares are listed on the NYSE. The proposed broker is J.P. Morgan Securities LLC.
The shares were acquired on 03/09/2021 as compensation, matching the amount to be sold (30,000). Shares outstanding were 60,152,407 as of the filing context. This is a notice of a potential secondary sale by a holder, not an issuance by the company.
Delek US Holdings insider Mark Wayne Hobbs, the company’s EVP, Chief Financial Officer, reported a transaction on 10/01/2025 showing 1,450 shares of common stock were disposed of at a price of $32.48 per share. The filing lists 45,548 shares beneficially owned by Mr. Hobbs after the reported transaction. The filing uses transaction code F(1) and includes an explanation that the shares were withheld for tax purposes upon vesting of equity awards, indicating the disposition was a tax-related withholding rather than an open-market sale. The Form 4 is signed on behalf of the reporting person by an attorney-in-fact and records the officer relationship to the issuer, Delek US Holdings, Inc. (DK).
Insider transaction summary: Robert G. Wright, identified on this Form 4 as an officer (SVP & Deputy CFO) of Delek US Holdings, Inc. (DK), had 1,382 shares withheld for tax purposes upon vesting of equity awards on 09/10/2025 at an indicated price of $29.71 per share. After the withholding, Mr. Wright beneficially owned 46,912 shares. The filing was submitted and signed by an attorney-in-fact on 09/12/2025. The filing notes the withholding was to satisfy tax obligations and does not report open-market purchases or voluntary dispositions.